Predictors of Adherence to Orencia.
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2010
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 20 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2010 New trial record